ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TBET Tibet Pharmaceuticals Inc (CE)

0.000001
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Tibet Pharmaceuticals Inc (CE) USOTC:TBET OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In Tibet Pharmaceuticals Inc. To Contact ...

02/06/2012 12:20am

PR Newswire (US)


Tibet Pharmaceuticals (CE) (USOTC:TBET)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Tibet Pharmaceuticals (CE) Charts.

NEW YORK, June 1, 2012 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Tibet Pharmaceuticals, Inc. ("Tibet Pharmaceuticals" or the "Company") (OTC: TBET).

(Logo:  http://photos.prnewswire.com/prnh/20120119/MM38856LOGO )

The investigation focuses on whether the Company and its executives violated federal securities laws by failing to disclose that Tibet Pharmaceuticals misrepresented and failed to disclose material internal control deficiencies, which rendered the Company's registration statement and prospectus to be materially false and misleading. These problems ultimately caused NASDAQ to halt and delist the Company's stock.

Request more information now by clicking here:  www.faruqilaw.com/TBET

Take Action

If you purchased Tibet Pharmaceutical securities after December 28, 2010 and would like to discuss your legal rights, visit www.faruqilaw.com/TBET.  You can also contact us by calling Juan Monteverde, Richard Gonnello or Francis McConville toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to jmonteverde@faruqilaw.com, rgonnello@faruqilaw.com or fmcconville@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Tibet Pharmaceutical's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.



Attorney Advertising.  The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).  Prior results do not guarantee or predict a similar outcome with respect to any future matter.  We welcome the opportunity to discuss your particular case.  All communications will be treated in a confidential matter.

FARUQI & FARUQI, LLP

369 Lexington Avenue, 10th Floor

New York, NY 10017

Attn:  Juan E. Monteverde, Esq.

jmonteverde@faruqilaw.com

Richard Gonnello, Esq.

rgonnello@faruqilaw.com

Francis McConville, Esq.

fmcconville@faruqilaw.com

Telephone: (877) 247-4292 or (212) 983-9330

SOURCE Faruqi & Faruqi, LLP

Copyright 2012 PR Newswire

1 Year Tibet Pharmaceuticals (CE) Chart

1 Year Tibet Pharmaceuticals (CE) Chart

1 Month Tibet Pharmaceuticals (CE) Chart

1 Month Tibet Pharmaceuticals (CE) Chart

Your Recent History

Delayed Upgrade Clock